Apolipoprotein E and α-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease
- 1 August 1999
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 270 (3) , 129-132
- https://doi.org/10.1016/s0304-3940(99)00468-1
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Increased levels of α-1-antichymotrypsin in brains of patients with Alzheimer's disease correlate with activated astrocytes and are affected by APOE 4 genotypeJournal of Neuroimmunology, 1998
- A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementiaNature Genetics, 1998
- No Genetic Effect of α1-Antichymotrypsin in Alzheimer DiseaseGenomics, 1996
- A4POE*4-associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphismNature Genetics, 1995
- The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, ColoradoAtherosclerosis, 1995
- Acute Phase Reactant α1Antichymotrypsin Is Increased in Cerebrospinal Fluid and Serum of Patients with Probable Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 1995
- Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filamentsNature, 1994
- ?1-Antichymotrypsin Binding to Alzheimer A? Peptides Is Sequence Specific and Induces Fibril Disaggregation In VitroJournal of Neurochemistry, 1993
- The role of the acute-phase protein α1-antichymotrypsin in brain dysfunction and injuryResearch in Immunology, 1992
- Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell BiologyScience, 1988